Actively Recruiting
Mirror Therapy Rehabilitation of the Upper Limb After Stroke (NEURO-MIROIR 2)
Led by Clinique Les Trois Soleils · Updated on 2026-03-18
66
Participants Needed
5
Research Sites
450 weeks
Total Duration
On this page
Sponsors
C
Clinique Les Trois Soleils
Lead Sponsor
C
Clinalliance Villiers-sur-Orge
Collaborating Sponsor
AI-Summary
What this Trial Is About
Hemiparesis is a common motor disorder after a stroke. The majority of patients do not recover functional use of their paretic upper limb. The use of mirror therapy allows the activation of the mirror neurons involved to stimulate brain plasticity after brain damage.The IVS (Intensive Visual Stimulation) device allows an easy implementation of mirror therapy by filming the valid upper limb and projecting the inverted image onto a screen placed above the parietal arm thus producing the illusion of movement of the parietal arm. The main hypothesis of this study is that the structured practice of a large number of upper limb targeted movement repetitions using an intensive visual numerical simulation device as a partial replacement for routine care (conventional occupational therapy) in the sub-acute phase of stroke will increase the active function (motor function and functional abilities) of the distal end of the upper limb compared to conventional rehabilitation. Objectives: This randomized controlled trial will evaluate the effects of partial substitution of routine care (occupational therapy) by structured movement repetition programs by Intensive Visual Simulation using an IVS3 device, on the distal motor control of the upper hemiparesis limb, between 4 and 10 weeks after the stroke, compared to a program with conventional care alone.
CONDITIONS
Official Title
Mirror Therapy Rehabilitation of the Upper Limb After Stroke (NEURO-MIROIR 2)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older
- Stroke hemiparesis from a unilateral focal lesion dated 4 to 10 weeks before baseline
- Fugl-Meyer wrist and hand total sub-scores less than 16
- Patient agrees to sign an informed consent
- Patient is affiliated with French Social Security
You will not qualify if you...
- Cognitive dysfunction or progressive illness preventing effective communication or participation
- Phasic disorders preventing understanding of instructions
- Participation in another clinical trial
- Neurological conditions before the stroke
- Prior mirror therapy or IVS rehabilitation before inclusion
- Rheumatological disease of the hand and wrist
- Person under legal protection measures
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 5 locations
1
CHU Sébastopol
Reims, Champagne-Ardenne, France, 51092
Not Yet Recruiting
2
Clinique Napoléon
Saint-Paul-lès-Dax, New Aquitaine, France, 40990
Not Yet Recruiting
3
Clinique Les Trois Soleils
Boissise-le-Roi, France, 77310
Actively Recruiting
4
CRF Pasori
Cosne-Cours-sur-Loire, France, 58200
Actively Recruiting
5
Clinalliance Villiers-sur Orge
Villiers-sur-Orge, France, 91700
Actively Recruiting
Research Team
S
SAS Les POMPON
CONTACT
C
Christophe DURET, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here